Retrospective Cohort Study of Caveolin-1 Expression as Prognostic Factor in Unresectable Locally Advanced or Metastatic Pancreatic Cancer Patients

被引:3
作者
Bittoni, Alessandro [1 ]
Giampieri, Riccardo [1 ]
Pecci, Federica [1 ]
Pinterpe, Giada [1 ]
Mandolesi, Alessandra [2 ]
Del Prete, Michela [3 ]
Zizzi, Antonio [2 ]
Crocetti, Sonia [1 ]
Liguori, Carolina [1 ]
Mentrasti, Giulia [1 ]
Cantini, Luca [1 ]
Pellei, Chiara [1 ,4 ]
Bisonni, Renato [3 ]
Scarpelli, Marina [2 ]
Berardi, Rossana [1 ]
机构
[1] Univ Politecn Marche, Med Oncol Unit, Azienda Ospedaliero Univ Ospedali Riuniti Umberto, I-60126 Ancona, Italy
[2] Azienda Ospedaliero Univ Ospedali Riuniti Umberto, Dept Pathol Anat & Histopathol, I-60126 Ancona, Italy
[3] Osped A Murri, Med Oncol Unit, I-63900 Fermo, Italy
[4] Osped Madonna Soccorso, Med Oncol Unit, I-63074 San Benedetto Tronto, Italy
关键词
Caveolin-1; pancreatic cancer; 1st line chemotherapy; prognosis; GEMCITABINE; FOLFIRINOX; SURVIVAL;
D O I
10.3390/curroncol28050303
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Caveolin-1 (Cav-1) plays a key role in various neoplastic diseases and is upregulated in different cancers, including pancreatic ductal adenocarcinoma (PDAC). Furthermore, Cav-1 is critical for the uptake of albumin as well as nab-paclitaxel in PDAC cells. Here, we investigated the prognostic impact of Cav-1 expression in a cohort of 39 metastatic PDAC patients treated with different first-line chemotherapy regimens. We also assessed the predictive value of Cav-1 in patients treated with gemcitabine and nab-paclitaxel. Cav-1 expression was evaluated by immunohistochemistry staining in neoplastic and stromal cells, using metastatic sites or primary tumor tissue specimens. Higher levels of Cav-1 expression were associated with significantly worse overall survival (OS) and progression-free survival (PFS). No differences in OS were found between patients treated with gemcitabine + nab-paclitaxel vs. other chemotherapy options. Multivariate analysis for OS and PFS confirmed the independent prognostic role of Cav-1 expression. Our study evidenced a negative prognostic role of Cav-1 in patients affected by metastatic/locally advanced unresectable PDAC. Moreover, Cav-1 expression seems not to predict different response rates to different types of first-line treatment. Future prospective trials will be necessary to confirm the prognostic role of Cav-1 and explore Cav-1 specific inhibitors as a therapeutic option for advanced PDAC patients.
引用
收藏
页码:3525 / 3536
页数:12
相关论文
共 37 条
[1]   Expression Profiling of Circulating Tumor Cells in Pancreatic Ductal Adenocarcinoma Patients: Biomarkers Predicting Overall Survival [J].
Amantini, Consuelo ;
Morelli, Maria Beatrice ;
Nabissi, Massimo ;
Piva, Francesco ;
Marinelli, Oliviero ;
Maggio, Federica ;
Bianchi, Francesca ;
Bittoni, Alessandro ;
Berardi, Rossana ;
Giampieri, Riccardo ;
Santoni, Giorgio .
FRONTIERS IN ONCOLOGY, 2019, 9
[2]  
Boscher C, 2012, ADV EXP MED BIOL, V729, P29, DOI 10.1007/978-1-4614-1222-9_3
[3]   High Clinical Value of Liquid Biopsy to Detect Circulating Tumor Cells and Tumor Exosomes in Pancreatic Ductal Adenocarcinoma Patients Eligible for Up-Front Surgery [J].
Buscail, Etienne ;
Alix-Panabieres, Catherine ;
Quincy, Pascaline ;
Cauvin, Thomas ;
Chauvet, Alexandre ;
Degrandi, Olivier ;
Caumont, Charline ;
Verdon, Severine ;
Lamrissi, Isabelle ;
Moranvillier, Isabelle ;
Buscail, Camille ;
Marty, Marion ;
Laurent, Christophe ;
Vendrely, Veronique ;
Moreau-Gaudry, Francois ;
Bedel, Aurelie ;
Dabernat, Sandrine ;
Chiche, Laurence .
CANCERS, 2019, 11 (11)
[4]   Cell Intrinsic and Extrinsic Mechanisms of Caveolin-1-Enhanced Metastasis [J].
Campos, America ;
Burgos-Ravanal, Renato ;
Fernanda Gonzalez, Maria ;
Huilcaman, Ricardo ;
Lobos Gonzalez, Lorena ;
Geoffery Quest, Andrew Frederick .
BIOMOLECULES, 2019, 9 (08)
[5]   Caveolae-Mediated Endocytosis Is Critical for Albumin Cellular Uptake and Response to Albumin-Bound Chemotherapy [J].
Chatterjee, Moumita ;
Ben-Josef, Edgar ;
Robb, Ryan ;
Vedaie, Marall ;
Seum, Star ;
Thirumoorthy, Krishnan ;
Palanichamy, Kamalakannan ;
Harbrecht, Matthew ;
Chakravarti, Arnab ;
Williams, Terence M. .
CANCER RESEARCH, 2017, 77 (21) :5925-5937
[6]   Caveolin-1 is Associated with Tumor Progression and Confers a Multi-Modality Resistance Phenotype in Pancreatic Cancer [J].
Chatterjee, Moumita ;
Ben-Josef, Edgar ;
Thomas, Dafydd G. ;
Morgan, Meredith A. ;
Zalupski, Mark M. ;
Khan, Gazala ;
Robinson, Charles Andrew ;
Griffith, Kent A. ;
Chen, Ching-Shih ;
Ludwig, Thomas ;
Bekaii-Saab, Tanios ;
Chakravarti, Arnab ;
Williams, Terence M. .
SCIENTIFIC REPORTS, 2015, 5
[7]   Association of Caveolin-1 Expression With Prostate Cancer: A Systematic Review and Meta-Analysis [J].
Chen, Pei ;
Zhang, Yu-ling ;
Xue, Bai ;
Xu, Guo-ying .
FRONTIERS IN ONCOLOGY, 2021, 10
[8]   FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer [J].
Conroy, T. ;
Hammel, P. ;
Hebbar, M. ;
Ben Abdelghani, M. ;
Wei, A. C. ;
Raoul, J. -L. ;
Chone, L. ;
Francois, E. ;
Artru, P. ;
Biagi, J. J. ;
Lecomte, T. ;
Assenat, E. ;
Faroux, R. ;
Ychou, M. ;
Volet, J. ;
Sauvanet, A. ;
Breysacher, G. ;
Di Fiore, F. ;
Cripps, C. ;
Kavan, P. ;
Texereau, P. ;
Bouhier-Leporrier, K. ;
Khemissa-Akouz, F. ;
Legoux, J. -L. ;
Juzyna, B. ;
Gourgou, S. ;
O'Callaghan, C. J. ;
Jouffroy-Zeller, C. ;
Rat, P. ;
Malka, D. ;
Castan, F. ;
Bachet, J. -B. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (25) :2395-2406
[9]   FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer [J].
Conroy, Thierry ;
Desseigne, Francoise ;
Ychou, Marc ;
Bouche, Olivier ;
Guimbaud, Rosine ;
Becouarn, Yves ;
Adenis, Antoine ;
Raoul, Jean-Luc ;
Gourgou-Bourgade, Sophie ;
de la Fouchardiere, Christelle ;
Bennouna, Jaafar ;
Bachet, Jean-Baptiste ;
Khemissa-Akouz, Faiza ;
Pere-Verge, Denis ;
Delbaldo, Catherine ;
Assenat, Eric ;
Chauffert, Bruno ;
Michel, Pierre ;
Montoto-Grillot, Christine ;
Ducreux, Michel .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (19) :1817-1825
[10]   Human pancreatic tumor cells are sensitized to ionizing radiation by knockdown of caveolin-1 [J].
Cordes, N. ;
Frickz, S. ;
Brunner, T. B. ;
Pilarsky, C. ;
Gruetzmann, R. ;
Siposs, B. ;
Kloeppels, G. ;
McKenna, W. G. ;
Bernhard, E. J. .
ONCOGENE, 2007, 26 (48) :6851-6862